Boston Partners’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-331,776
Closed -$1.12M 765
2023
Q3
$1.12M Buy
331,776
+9,919
+3% +$65.2K ﹤0.01% 541
2023
Q2
$2.67M Buy
321,857
+65,341
+25% +$588K ﹤0.01% 459
2023
Q1
$2.24M Sell
256,516
-43,237
-14% -$480K ﹤0.01% 455
2022
Q4
$3.66M Buy
299,753
+46,877
+19% +$446K 0.01% 395
2022
Q3
$1.61M Buy
252,876
+116,722
+86% +$987K ﹤0.01% 468
2022
Q2
$1.22M Buy
+136,154
New +$1.2M ﹤0.01% 482

Other funds holding SGHT

Boston Partners's SGHT Position: Q4 2023 in Review

Boston Partners sold out of Sight Sciences (SGHT) in Q4 2023, closing a stake of 331,776 shares — an estimated $1.12M sold.

Boston Partners first reported a position in SGHT in Q2 2022 and held it in 6 quarters. The position peaked at $3.66M in Q4 2022. 65 funds tracked by Wall St. Rank hold SGHT as of Q4 2023.

  • Boston Partners reported no remaining Sight Sciences position as of Q4 2023 after selling out during the quarter.
  • Boston Partners sold 331,776 Sight Sciences shares in Q4 2023, an estimated $1.12M.
  • Boston Partners first reported a position in Sight Sciences in Q2 2022 and held it in 6 quarters.
  • Boston Partners's Sight Sciences position peaked at $3.66M in Q4 2022.
  • 65 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2023.

Based on Boston Partners's 13F filing for Q4 2023, filed 7 Feb 2024.